MedTrace Logo

Lifestyle Modification Programme for Patients With Peripheral Arterial Disease

NCT03935776 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2021-08-04

No results posted yet for this study

Summary

This trial randomises patients with occlusive peripheral arterial disease, to be managed either by providing a 12-week structured lifestyle modification programme, or standard healthcare.

Conditions

  • Peripheral Arterial Occlusive Disease

Interventions

BEHAVIORAL

Risk Factors Modification Programme

12- week supervised risk factor modification programme derived from the Euroaction study standards

BEHAVIORAL

Standard Healthcare

Patients are advised to adjust lifestyle without the support of the structured supervised programme

Sponsors & Collaborators

  • Western Vascular Institute, Ireland

    lead OTHER

Principal Investigators

  • Wael Tawfick, MB BcH,MRCSI · Western Vascular Institute, Ireland

  • Sherif Sultan, MB BcH,MRCSI · Western Vascular Institute, Ireland

  • Marah Elfghi, MB BcH, MSc · Western Vascular Institute, Ireland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03935776 on ClinicalTrials.gov